Sandoz Group AG (SDZNY)
35.23
-0.76
(-2.11%)
USD |
OTCM |
May 17, 15:59
Sandoz Group Price: 35.23 for May 17, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 17, 2024 | 35.16 | 35.34 | 35.03 | 35.23 | 42175.00 |
May 16, 2024 | 35.60 | 36.04 | 35.33 | 35.99 | 209979.0 |
May 15, 2024 | 35.41 | 35.90 | 35.29 | 35.77 | 55782.00 |
May 14, 2024 | 35.12 | 35.35 | 35.10 | 35.29 | 58402.00 |
May 13, 2024 | 35.42 | 35.73 | 35.36 | 35.42 | 44435.00 |
May 10, 2024 | 35.91 | 36.13 | 35.90 | 35.98 | 80332.00 |
May 09, 2024 | 34.36 | 35.08 | 34.36 | 34.97 | 49425.00 |
May 08, 2024 | 34.49 | 34.87 | 34.48 | 34.60 | 43947.00 |
May 07, 2024 | 33.89 | 33.89 | 33.20 | 33.20 | 165005.0 |
May 06, 2024 | 34.35 | 35.00 | 34.01 | 34.24 | 289123.0 |
May 03, 2024 | 33.83 | 34.45 | 33.83 | 34.21 | 38818.00 |
May 02, 2024 | 33.96 | 34.21 | 33.82 | 33.95 | 35916.00 |
May 01, 2024 | 32.80 | 34.50 | 32.80 | 33.95 | 71002.00 |
Apr 30, 2024 | 33.89 | 34.25 | 33.78 | 33.88 | 86954.00 |
Apr 29, 2024 | 33.18 | 33.78 | 33.15 | 33.61 | 108054.0 |
Apr 26, 2024 | 32.52 | 32.99 | 32.48 | 32.80 | 256082.0 |
Apr 25, 2024 | 33.75 | 33.78 | 33.40 | 33.64 | 125887.0 |
Apr 24, 2024 | 33.35 | 33.53 | 33.29 | 33.45 | 33654.00 |
Apr 23, 2024 | 34.02 | 34.10 | 33.37 | 33.58 | 979183.0 |
Apr 22, 2024 | 33.34 | 34.28 | 33.34 | 34.02 | 540571.0 |
Apr 19, 2024 | 32.03 | 32.50 | 32.03 | 32.32 | 122993.0 |
Apr 18, 2024 | 31.70 | 31.86 | 31.27 | 31.34 | 94150.00 |
Apr 17, 2024 | 30.61 | 30.83 | 30.47 | 30.74 | 97048.00 |
Apr 16, 2024 | 30.56 | 30.65 | 30.40 | 30.56 | 582222.0 |
Apr 15, 2024 | 30.49 | 30.83 | 30.41 | 30.45 | 155667.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
25.82
Minimum
Oct 31 2023
35.99
Maximum
May 16 2024
31.17
Average
31.61
Median
Mar 18 2024
Price Benchmarks
Novartis AG | 102.57 |
AC Immune SA | 3.21 |
CRISPR Therapeutics AG | 56.19 |
Addex Therapeutics Ltd | 8.79 |
NLS Pharmaceutics Ltd | 0.1533 |
Price Related Metrics
PE Ratio | 21.48 |
PS Ratio | 9.274 |
Earnings Yield | 4.66% |
Market Cap | 15.15B |
Operating PE Ratio | 16.63 |
Normalized PE Ratio | 19.42 |